Episode 2 - Tamiflu Generic, Biosimilars, Pricing and Policy Implications

December 16, 2016

In this episode, I discuss what it means now that Tamiflu generic has been approved and introduced in several markets.  Generics and biosimilars are explained within the context of drug development and commercialization.  Pricing discussion continues around original v generic/biosimilar drugs and what policy may help more effective pricing.  15 min.

00:0000:00

Facebook Comments: